1. Home
  2. TCBK vs EWTX Comparison

TCBK vs EWTX Comparison

Compare TCBK & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$48.54

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$23.03

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBK
EWTX
Founded
1975
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TCBK
EWTX
Price
$48.54
$23.03
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$48.60
$37.30
AVG Volume (30 Days)
123.6K
1.3M
Earning Date
01-22-2026
11-06-2025
Dividend Yield
2.96%
N/A
EPS Growth
5.66
N/A
EPS
3.55
N/A
Revenue
$399,268,000.00
N/A
Revenue This Year
$9.49
N/A
Revenue Next Year
$5.50
N/A
P/E Ratio
$13.72
N/A
Revenue Growth
3.12
N/A
52 Week Low
$35.20
$10.60
52 Week High
$49.71
$35.50

Technical Indicators

Market Signals
Indicator
TCBK
EWTX
Relative Strength Index (RSI) 68.06 61.03
Support Level $47.45 $21.72
Resistance Level $49.09 $26.30
Average True Range (ATR) 1.03 1.50
MACD 0.30 0.14
Stochastic Oscillator 92.57 53.19

Price Performance

Historical Comparison
TCBK
EWTX

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: